Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age25-80
SponsorM.D. Anderson Cancer Center

About this trial

This study collects mammogram images, blood samples, and clinical information from women undergoing routine screening mammograms. Creating a bank of blood samples and a database of clinical and risk information may be used in future research related to breast cancer, other cancers, and women's health.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Willingness to participate in the study and ability to provide informed consent

Willingness to complete a questionnaire and to provide a blood sample at the initial visit and at follow up annual visits

Undergoing a screening mammogram at participating sites. Subjects undergoing routine annual diagnostic mammograms or CEM as part of a screening study are also eligible.

Disqualifiers

Current or recent (within the prior 6 months) history of breast feeding

Personal history of breast cancer (ductal breast carcinoma in situ [DCIS] or invasive breast cancer)

Personal history of any other cancer (excluding in-situ, stage 0, and non-melanoma skin cancers and other pre-cancerous conditions) treated within the last 5 years.

Trial population

Participants receiving screening mammograms at MD Anderson site

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Biospecimen Collection

    Procedure/Surgery

    Undergo collection of blood samples

  • Mammography

    Procedure/Surgery

    Undergo standard of care mammography

  • Questionnaire Administration

    Other intervention

    Complete questionnaires

Treatment groups

10,000 Participants
are divided into 1 treatment group
Group A: Observational (mammography, questionnaires, blood collection)3 interventions

Trial outcomes

Primary outcomes

1

Creation of a repository of blood specimens and database of imaging, clinical data, health measurements, and questionnaire data

Time frame
5 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

M.D. Anderson Cancer Center

Lead sponsor

National Cancer Institute (NCI)

Collaborator